Oncotarget

Corrections:

Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer

Yinghong Pan, Gordon Robertson, Lykke Pedersen, Emilia Lim, Anadulce Hernandez-Herrera, Amy C. Rowat, Sagar L. Patil, Clara K. Chan, Yunfei Wen, Xinna Zhang, Upal Basu-Roy, Alka Mansukhani, Andy Chu, Payal Sipahimalani, Reanne Bowlby, Denise Brooks, Nina Thiessen, Cristian Coarfa, Yussanne Ma, Richard A. Moore, Jacquie E. Schein, Andrew J. Mungall, Jinsong Liu, Chad V. Pecot, Anil K. Sood, Steven J.M. Jones, Marco A. Marra and Preethi H. Gunaratne _

PDF  |  How to cite

Oncotarget. 2017; 8:17406-17406. https://doi.org/10.18632/oncotarget.15921

Metrics: PDF 2681 views  |   ?  

Present:

ACKNOWLEDGEMENTS

The authors gratefully acknowledge the data production teams at the Genome Sciences Centre.

Corrected:

ACKNOWLEDGEMENTS

Corrected: The authors gratefully acknowledge the data production teams at the Genome Sciences Centre. The results published here are in whole or part based upon data generated by The Cancer Genome Atlas managed by the NCI and NHGRI. Information about TCGA can be found at http://cancergenome.nih.gov.

Original article: Oncotarget. 2016; 7(18):25930-48. DOI: 10.18632/oncotarget.8412.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15921